You are here

PrEP approved for PBS

As anticipated, the Pharmaceutical Benefits Advisory Committee (PBAC) announced its decision to recommend PrEP for federal subsidy. Releasing a statement in response to the news, the Australian Federation of AIDS Organisations (AFAO) considered the move a “critical step towards dramatically reducing HIV transmission in Australia”.  

Should PBAC approve PrEP, federal health minister Greg Hunt had already given a commitment to list the drug on the PBS ASAP. This will cut the cost of the HIV prevention drug, Truvada, from $850 a month to $35.90. An estimated 31,000 people — mostly men who have sex with men — will benefit from today’s announcement. “Gay and bisexual men continue to carry the greatest burden of HIV in Australia, and we expect that PrEP will sharply drive down the rates of HIV for this community,” said AFAO chief executive, Darryl O’Donnell.

Before today’s watershed decision, PrEP was only available in Australia through state-funded trials, at retail prices via a prescription from a GP, or online imports. Now that PrEP is to be made widely — and affordably — available, it is hoped that it will usher in an era of shared responsibility around HIV prevention. “Equitable access to PrEP for HIV-negative people is an important advancement for those already living with HIV. It will help counter stigma and discrimination against people living with HIV,” said Cipri Martinez, president of the National Association of People Living with HIV Australia. “By keeping those at risk of HIV safe, PrEP gives both partners control and confidence. This helps everyone share responsibility for HIV prevention equally.”

Describing PrEP as a “necessary and urgent tool”, Nic Holas, co-founder of The Institute of Many (TIM) — a peer-support group for positive people, agreed: “For too long, people living with HIV have borne the brunt of expectation, responsibility, and blame when it comes to keeping the community safe from HIV. PrEP offers HIV-negative people the opportunity to take more responsibility for their own safety.”

While celebrating PrEP’s approval, O’Donnell said it is important that no-one who wants the drug is left behind. “While PBS listing of PrEP is critical, we must make sure everyone who needs PrEP is aware of it and can access it.”


latest news

February 12, 2018
The annual awareness day on 9 March is aimed at encouraging women to test for HIV.
February 9, 2018
As anticipated, today the decision was announced to recommend PrEP for federal subsidy.
January 22, 2018
Once again, 9 March commemorates the National Day of Women Living with HIV Australia. 
August 22, 2017
A decision to subsidise PrEP has been deferred, much to the disappointment and frustration of HIV advocates.
July 26, 2017
Results from an Australian study show that HIV-positive men on treatment cannot transmit the virus.
June 22, 2017
Why is an easily curable disease once believed to be on the wane in Australia out of control?
June 6, 2017
Real-life exchanges between people on Grindr are at the centre of a new campaign spotlighting HIV stigma.
June 5, 2017
This year marks the 30th anniversary of ACT UP and many of today’s survivors were yesterday’s activists.
June 5, 2017
Here, a group of long-term survivors shed light on on the dark days of the AIDS epidemic. 
June 5, 2017
Using gene-editing technology, scientists successfully eliminate HIV in live animals. 
June 5, 2017
A grassroots organisation is calling for Australia's blood donation rules to be relaxed.
June 5, 2017
HIV enters the brain within the early stages of infection — just a matter of a few weeks. 
June 5, 2017
David Menadue rifles through the PL archives to look back at the watershed year of 1996.
June 5, 2017
Long-term survivors of HIV find themselves on a new and unexpected battlefront: ageing with HIV. 
May 1, 2017
Flu season is here, and people — especially those with impaired immunity — are advised to get vaccinated.